Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Public Sector Undertaking (PSU) under the Department of Biotechnology, Ministry of Science and Technology, Government of India. Established in 1989 and headquartered in Bulandshahar, Uttar Pradesh, BIBCOL plays a crucial role in India’s healthcare sector by manufacturing and supplying essential vaccines and immunizers.

BIBCOL is renowned for producing oral polio vaccines (OPVs), which are vital in the fight against polio in India. The company formulates over 125 million doses of OPV annually. In addition to OPVs, BIBCOL manufactures other critical healthcare products, including zinc dispersible tablets, which are used to manage diarrhea among young children, and Iron Folic Acid (IFA) tablets, which help combat iron-deficiency anemia.

The company is committed to innovation and quality, ensuring that its products meet international standards. BIBCOL’s efforts have significantly contributed to public health initiatives in India, particularly in rural and underserved areas. The company’s infrastructure includes state-of-the-art manufacturing facilities and research laboratories, enabling it to maintain high standards of production and quality control.

BIBCOL’s mission is to support national health programs and contribute to the global fight against infectious diseases through the production of high-quality vaccines and immunizers